Strength
25 mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850089201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
LOXAPINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA076868On Market Since
1/27/2020
Related Drugs
Same classification
No related drugs found.